Argenta Discovery is a respiratory-focused pharmaceutical R&D company. Argenta is developing a pipeline of novel therapies to treat serious diseases such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma and cystic fibrosis (CF) with the aim of delivering both improved symptomatic relief and treating the underlying inflammatory disease process. Argenta intends to progress its programmes through Phase IIa proof of concept clinical trials before partnering.
